Electrohydraulic impactor for peripheral arterial occlusion management
用于外周动脉闭塞治疗的电动液压冲击器
基本信息
- 批准号:10256269
- 负责人:
- 金额:$ 26.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAmericanAmputationAngioplastyAnimalsArterial Occlusive DiseasesArteriesAtherectomyBalloon AngioplastyBiliary calculiBlood VesselsBlood flowBypassCadaverCathetersChronicClinicalCollaborationsComplexConsultDevelopmentDevice or Instrument DevelopmentDevicesDiagnostic radiologic examinationDiseaseDissectionDistalDoctor of PhilosophyEffectivenessElectrical EngineeringElectrodesFutureGoalsGrantHistologyHospitalsHumanImpairmentInterventionInvestigationLaboratoriesLasersLegLesionLimb structureLithotripsyMeasurementMechanicsMedical DeviceMedical Device DesignsMedical RecordsMethodsModelingModificationMorbidity - disease rateOperative Surgical ProceduresOptical Coherence TomographyPain in lower limbPatient-Focused OutcomesPatientsPerforationPerformancePerfusionPeripheralPeripheral arterial diseasePhasePhysiciansProceduresProcessRecoveryResearchResearch Project GrantsResistanceResourcesRiskRotational AtherectomiesStenosisStentsTechniquesTechnologyTestingTimeTissuesUreterolithiasisWomanartery occlusionbasecalcificationchronic ulcercommercializationdesigneffective therapyexperienceexperimental studyfootimprovedin vivo evaluationinsightlimb amputationlimb ischemialimb lossmedical schoolsmembernecrotic tissuenovelphysical sciencepre-clinicalpressurepreventprogramsresearch clinical testingsuccesstechnology developmenttool
项目摘要
Project Summary/Abstract
The primary goal of this research project is to develop and pre-clinically validate a novel electrohydraulic
impact (EHI) device that will aid clinicians in treating patients with peripheral artery chronic total occlusions
(CTOs). CTOs represent the complete blockage of the blood vessels and are difficult to recanalize using
traditional percutaneous transluminal angioplasty (PTA) techniques and apparatus. The presence of
calcifications and fibrotic tissues within CTOs, together with the vessel size and tortuosity, are the causes of
multiple complications during treatment. Therefore, a significant number of CTOs are treated using an invasive
bypass surgery, which has significant morbidity and requires extensive recovery time. The central challenge to
catheter based nonsurgical percutaneous CTO treatment is that it often is incredibly difficult to cross the
calcified and resistant chronic blockage with an angioplasty wire. Although efforts have been made to use
excimer lasers or rotational atherectomy devices (rotablator), these plaque modification devices require a wire
to cross the CTO, which limits their utility if no wire crossing is established. To address this clinically important
problem of difficult CTO crossing, Physical Sciences Inc. (PSI) in collaboration with Brigham and Women's
Hospital (BWH) and Impact Vascular (IVAS) proposes to develop and pre-clinically evaluate a novel and safer
method and device for CTO management. The proposed device uses an electrohydraulic impactor that creates
a directed impact pressure of several hundred bar to penetrate the CTO plaque without damaging normal elastic
arterial tissue. Therefore, EHI will facilitate CTO crossing and distal guide-wire passage to enable definitive
treatment with balloons and stents.
项目概要/摘要
该研究项目的主要目标是开发并进行临床前验证一种新型电动液压装置
冲击 (EHI) 装置将帮助临床医生治疗外周动脉慢性完全闭塞患者
(首席技术官)。 CTO 代表血管完全堵塞,很难使用
传统的经皮腔内血管成形术(PTA)技术和设备。的存在
CTO 内的钙化和纤维化组织,以及血管大小和弯曲度,是导致
治疗期间出现多种并发症。因此,大量 CTO 接受侵入性治疗
搭桥手术的发病率很高,并且需要很长的恢复时间。主要挑战是
基于导管的非手术经皮 CTO 治疗的缺点是通常很难跨越
用血管成形术丝治疗钙化且顽固的慢性阻塞。尽管已经努力使用
准分子激光器或旋磨设备(旋转器),这些斑块修改设备需要一根电线
跨越 CTO,如果没有建立电线交叉,就会限制其效用。为了解决这个临床上重要的问题
物理科学公司 (PSI) 与布莱根妇女医院合作解决了 CTO 穿越困难的问题
医院 (BWH) 和影响血管 (IVAS) 提议开发一种新型且更安全的药物并进行临床前评估
一种CTO管理方法及装置。所提出的装置使用电动液压冲击器来产生
数百巴的定向冲击压力可穿透 CTO 斑块而不损坏正常弹性
动脉组织。因此,EHI 将促进 CTO 交叉和远端导丝通道,以实现明确的
用球囊和支架治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NICUSOR IFTIMIA其他文献
NICUSOR IFTIMIA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NICUSOR IFTIMIA', 18)}}的其他基金
Smart sensor for guiding safe delivery of anesthetic and pain drugs through epidurals
智能传感器用于指导通过硬膜外麻醉剂和止痛药物的安全输送
- 批准号:
10545953 - 财政年份:2022
- 资助金额:
$ 26.31万 - 项目类别:
Intelligent Optical Probe for Guiding Core Needle Biopsy Procedures
用于引导核心针活检程序的智能光学探头
- 批准号:
10481578 - 财政年份:2022
- 资助金额:
$ 26.31万 - 项目类别:
Smart sensor for guiding safe delivery of anesthetic and pain drugs through epidurals
智能传感器用于指导通过硬膜外麻醉剂和止痛药物的安全输送
- 批准号:
10883933 - 财政年份:2022
- 资助金额:
$ 26.31万 - 项目类别:
Intelligent Optical Probe for Guiding Core Needle Biopsy Procedures
用于引导核心针活检程序的智能光学探头
- 批准号:
10625956 - 财政年份:2022
- 资助金额:
$ 26.31万 - 项目类别:
Optical probe for in situ assessment of pulmonary fibrosis
用于肺纤维化原位评估的光学探头
- 批准号:
9907714 - 财政年份:2020
- 资助金额:
$ 26.31万 - 项目类别:
Endoscopic Multifunctional Optical Coherence Tomography for Airway Tissue Injury Management
用于气道组织损伤管理的内窥镜多功能光学相干断层扫描
- 批准号:
10081106 - 财政年份:2020
- 资助金额:
$ 26.31万 - 项目类别:
Multimodal Optical Probe for Skin Cancer Detection and Therapy Guidance
用于皮肤癌检测和治疗指导的多模态光学探头
- 批准号:
10206472 - 财政年份:2019
- 资助金额:
$ 26.31万 - 项目类别:
Multimodal Optical Probe for Skin Cancer Detection and Therapy Guidance
用于皮肤癌检测和治疗指导的多模态光学探头
- 批准号:
10224140 - 财政年份:2019
- 资助金额:
$ 26.31万 - 项目类别:
IGF::OT::IGF: SBIR PHASE II, TOPIC 331: OPTICAL BIOSENSOR FOR REAL-TIME ASSESSMENT OF TUMOR CELLULARITY DURING CORE NEEDLE BIOPSY PROCEDURES.
IGF::OT::IGF:SBIR 第二阶段,主题 331:用于在芯针活检过程中实时评估肿瘤细胞性的光学生物传感器。
- 批准号:
9360347 - 财政年份:2016
- 资助金额:
$ 26.31万 - 项目类别:
IGF::OT::IGF SBIR PHASE I TOPIC 331: OPTICAL BIOSENSOR FOR REAL-TIME ASSESSMENT OF TUMOR CELLULARITY DURING CORE NEEDLE BIOPSY
IGF::OT::IGF SBIR 第一阶段主题 331:用于芯针活检期间实时评估肿瘤细胞性的光学生物传感器
- 批准号:
8945534 - 财政年份:2014
- 资助金额:
$ 26.31万 - 项目类别:
相似海外基金
Examining linkages between disrupted care and chronic disease outcomes during the COVID-19 pandemic: a VAMC level spatio-temporal analysis
检查 COVID-19 大流行期间中断的护理与慢性病结果之间的联系:VAMC 级别时空分析
- 批准号:
10641136 - 财政年份:2023
- 资助金额:
$ 26.31万 - 项目类别:
Sensory Augmentation, Restoration, and Modulation Using a Spinal Neuroprosthesis
使用脊柱神经假体进行感觉增强、恢复和调节
- 批准号:
10687329 - 财政年份:2023
- 资助金额:
$ 26.31万 - 项目类别:
Implementation of a Medication Adherence Instrument among Patients with Symptomatic Peripheral Artery Disease after Peripheral Vascular Intervention
在周围血管介入治疗后有症状的周围动脉疾病患者中实施药物依从性工具
- 批准号:
10739335 - 财政年份:2023
- 资助金额:
$ 26.31万 - 项目类别:
Quantifying proteins in plasma do democratize personalized medicine for patients with type 1 diabetes
量化血浆中的蛋白质确实使 1 型糖尿病患者的个性化医疗民主化
- 批准号:
10730284 - 财政年份:2023
- 资助金额:
$ 26.31万 - 项目类别:
Strain-Programmed Bioadhesive Patch for Enhanced Diabetic Wound Healing
用于增强糖尿病伤口愈合的应变程序生物粘附贴片
- 批准号:
10818916 - 财政年份:2023
- 资助金额:
$ 26.31万 - 项目类别: